ung Ultrasound in Covid-19 Pneumonia

Not Applicable

• Conditions: J12.8; U07.1; Other viral pneumonia; COVID-19, virus identified

• Registration Number: DRKS00021585
• Lead Sponsor: Vivantes Humboldt Klinikum - Zentrale Notaufnahme

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-29
• Study Completion: 2021-04-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 222

Inclusion Criteria

acute respiratory symptoms (cough, sore throat) and one of three: dyspnea, age > 60, relevant comorbidity (Diabetes, cardiovascular or chronic pulmonary) and Temperature > 37.3°C or lymphopenia < 1.1 G/

Exclusion Criteria

not able to consent, lack of informed consent, unstable Patient, age < 18yrs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cohen`s kappa regarding the binary outcome pulmonary opacities/infiltrations yes/no by both Methods.

Secondary Outcome Measures

Name	Time	Method
sensitivity and specificity of lung ultrasound for pulmonary infiltrates